ECULLY
France
8
2014-11-13
5
2017-01-24
These are the the leading inventors for applications assigned to Alize Pharma SAS:
Alize Pharma SAS based in ECULLY, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
MODULATION OF GHRELIN LEVELS AND GHRELIN/UNACYLATED GHRELIN RATIO USING UNACYLATED GHRELIN
#2 | 2013-06-20 β Patent 9,550,821 granted on 2017-01-24Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin
#3 | 2011-10-06 β Patent 8,318,664 granted on 2012-11-27Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity
#4 | 2011-06-30UNACYLATED GHRELIN AND ANALOGS AS THERAPEUTIC AGENTS FOR VASCULAR REMODELING IN DIABETIC PATIENTS AND TREATMENT OF CARDIOVASCULAR DISEASE
#5 | 2010-08-05 β Patent 8,071,368 granted on 2011-12-06Methods for promoting growth and survival of insulin-secreting cells
#6 | 2010-07-01UNACYLATED GHRELIN AS THERAPEUTIC AGENT IN THE TREATMENT OF METABOLIC DISORDERS
#7 | 2010-01-21 β Patent 8,476,408 granted on 2013-07-02Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
#8 | 2008-12-18 β Patent 8,222,217 granted on 2012-07-17Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
82509 β